This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Harris, J. M. Articles by Muscat, G. E. O. Search for Related Content PubMed PubMed Citation Articles by Harris, J. M. Articles by Muscat, G. E. O.

Characterization of the Retinoid Orphan-Related Receptor- Coactivator Binding Interface: A Structural Basis for Ligand-Independent Transcription

Queensland University of Technology (J.M.H.), Centre for Molecular Biotechnology, Brisbane 4001, Queensland, Australia; and University of Queensland (P.L., S.L.C., G.E.O.M.) Institute for Molecular Bioscience, Australian Research Council Special Research Centre for Functional and Applied Genomics, Ritchie Research Laboratories, St. Lucia 4072, Queensland, Australia

Address all correspondence and requests for reprints to: A/Pr George E. O. Muscat, Institute for Molecular Bioscience, The University of Queensland, Research Road, Ritchie Building B402A, St. Lucia, Queensland 4072, Australia. E-mail: G.Muscat{at}imb.uq.edu.au.

The retinoid orphan-related receptor- (ROR) is a member of the ROR subfamily of orphan receptors and acts as a constitutive activator of transcription in the absence of exogenous ligands. To understand the basis of this activity, we constructed a homology model of ROR using the closely related TRß as a template. Molecular modeling suggested that bulky hydrophobic side chains occupy the ROR ligand cavity leaving a small but distinct cavity that may be involved in receptor stabilization. This model was subject to docking simulation with a receptor-interacting peptide from the steroid receptor coactivator, GR-interacting protein-1, which delineated a coactivator binding surface consisting of the signature motif spanning helices 3–5 and helix 12 [activation function 2 (AF2)]. Probing this surface with scanning alanine mutagenesis showed structural and functional equivalence between homologous residues of ROR and TRß. This was surprising (given that ROR is a ligand-independent activator, whereas TRß has an absolute requirement for ligand) and prompted us to use molecular modeling to identify differences between ROR and TRß in the way that the AF2 helix interacts with the rest of the receptor. Modeling highlighted a nonconserved amino acid in helix 11 of ROR (Phe491) and a short-length of 3.10 helix at the N terminus of AF2 which we suggest 1) ensures that AF2 is locked permanently in the holoconformation described for other liganded receptors and thus 2) enables ligand-independent recruitment of coactivators. Consistent with this, mutation of ROR Phe491 to either methionine or alanine (methionine is the homologous residue in TRß), reduced and ablated transcriptional activation and recruitment of coactivators, respectively. Furthermore, we were able to reconstitute transcriptional activity for both a deletion mutant of ROR lacking AF2, and Phe491Met, by overexpression of a GAL-AF2 fusion protein, demonstrating ligand-independent recruitment of AF2 and a role for Phe491 in recruiting AF2.

This article has been cited by other articles:

				H. Odawara, T. Iwasaki, J. Horiguchi, N. Rokutanda, K. Hirooka, W. Miyazaki, Y. Koibuchi, N. Shimokawa, Y. Iino, I. Takeyoshi, et al. Activation of Aromatase Expression by Retinoic Acid Receptor-related Orphan Receptor (ROR) {alpha} in Breast Cancer Cells: IDENTIFICATION OF A NOVEL ROR RESPONSE ELEMENT J. Biol. Chem., June 26, 2009; 284(26): 17711 - 17719. [Abstract] [Full Text] [PDF]

				J. Du, C. Huang, B. Zhou, and S. F. Ziegler Isoform-Specific Inhibition of ROR{alpha}-Mediated Transcriptional Activation by Human FOXP3 J. Immunol., April 1, 2008; 180(7): 4785 - 4792. [Abstract] [Full Text] [PDF]

				S. Das, M. Schapira, M. Tomic-Canic, R. Goyanka, T. Cardozo, and H. H. Samuels Farnesyl Pyrophosphate Is a Novel Transcriptional Activator for a Subset of Nuclear Hormone Receptors Mol. Endocrinol., November 1, 2007; 21(11): 2672 - 2686. [Abstract] [Full Text] [PDF]

				K D S. A. Wansa and G. E O Muscat TRAP220 is modulated by the antineoplastic agent 6-Mercaptopurine, and mediates the activation of the NR4A subgroup of nuclear receptors J. Mol. Endocrinol., June 1, 2005; 34(3): 835 - 848. [Abstract] [Full Text] [PDF]